Yasuda S et al (2004) Beta2-glycoprotein I, anti-beta2-glycoprotein I, and fibrinolysis. Thromb Res 114(5–6):461–465

Article  CAS  PubMed  Google Scholar 

McDonnell T et al (2020) The role of beta-2-glycoprotein I in health and disease associating structure with function: more than just APS. Blood Rev 39:100610

Article  CAS  PubMed  Google Scholar 

Pozzi N et al (2013) beta2 -Glycoprotein I binds to thrombin and selectively inhibits the enzyme procoagulant functions. J Thromb Haemost 11(6):1093–1102

Article  CAS  PubMed  Google Scholar 

Ninivaggi M et al (2012) Conformation of beta2glycoprotein I and its effect on coagulation. Thromb Res 130(Suppl 1):S33–S36

Article  CAS  PubMed  Google Scholar 

Yasuda S et al (2004) Nicked beta2-glycoprotein I: a marker of cerebral infarct and a novel role in the negative feedback pathway of extrinsic fibrinolysis. Blood 103(10):3766–3772

Article  CAS  PubMed  Google Scholar 

Ieko M et al (1999) Beta2-glycoprotein I is necessary to inhibit protein C activity by monoclonal anticardiolipin antibodies. Arthritis Rheum 42(1):167–174

Article  CAS  PubMed  Google Scholar 

Latov N (2004) Practice parameter: immunotherapy for Guillain-Barre syndrome: report of the quality standards subcommittee of the American academy of neurology. Neurology 62(9):1653–1654 author reply 1654

Article  PubMed  Google Scholar 

Hughes RA et al (2005) Supportive care for patients with Guillain-Barre syndrome. Arch Neurol 62(8):1194–1198

Article  PubMed  Google Scholar 

Bayry J et al (2003) Mechanisms of action of intravenous Immunoglobulin in autoimmune and inflammatory diseases. Neurol Sci 24(Suppl 4):S217–S221

Article  PubMed  Google Scholar 

Clynes R (2005) Immune complexes as therapy for autoimmunity. J Clin Invest 115(1):25–27

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kang GB et al (2023) Cation exchange chromatography removes FXIa from a 10% intravenous Immunoglobulin Preparation. Front Cardiovasc Med 10:1253177

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu YW et al (2014) Dedicated removal of Immunoglobulin (Ig)A, IgM, and factor (F)XI/activated FXI from human plasma IgG. Transfusion 54(1):169–178

Article  CAS  PubMed  Google Scholar 

El-Ekiaby M et al (2015) Minipool caprylic acid fractionation of plasma using disposable equipment: a practical method to enhance Immunoglobulin supply in developing countries. PLoS Negl Trop Dis 9(2):e0003501

Article  PubMed  PubMed Central  Google Scholar 

Daniel GW et al (2012) Immune globulins and thrombotic adverse events as recorded in a large administrative database in 2008 through 2010. Transfusion 52(10):2113–2121

Article  CAS  PubMed  Google Scholar 

Menis M et al (2013) Hyperimmune globulins and same-day thrombotic adverse events as recorded in a large healthcare database during 2008–2011. Am J Hematol 88(12):1035–1040

Article  CAS  PubMed  Google Scholar 

Sridhar G et al (2014) Immune globulins and same-day thrombotic events as recorded in a large health care database during 2008 to 2012. Transfusion 54(10):2553–2565

Article  PubMed  Google Scholar 

Ovanesov MV et al (2017) Association of immune Globulin intravenous and thromboembolic adverse events. Am J Hematol 92(4):E44–E45

Article  PubMed  Google Scholar 

Hemker HC et al (2002) The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb 32(5–6):249–253

Article  CAS  PubMed  Google Scholar 

Al Dieri R, de Laat B, Hemker HC (2012) Thrombin generation: what have we learned?Blood Rev 26(5):197–203

Article  CAS  PubMed  Google Scholar 

Liang Y et al (2021) Detecting factor XIa in immune Globulin products: commutability of international reference materials for traditional and global hemostasis assays. Res Pract Thromb Haemost 5(1):211–222

Article  CAS  PubMed  Google Scholar 

Lackner F et al (2014) Contamination of therapeutic human Immunoglobulin preparations with Apolipoprotein H (beta2-glycoprotein I). Electrophoresis 35(4):515–521

Article  CAS  PubMed  Google Scholar 

Parunov LA et al (2021) Thrombin generation test based on a 96-channel pipettor for evaluation of FXIa procoagulant activity in pharmaceuticals. Nat Protoc 16(8):3981–4003

Article  CAS  PubMed  Google Scholar 

Liang Y et al (2013) Correction of microplate location effects improves performance of the thrombin generation test. Thromb J 11(1):12

Article  PubMed  PubMed Central  Google Scholar 

Xin KZ, Chang WC, Ovanesov MV (2016) Interconnectedness of global hemostasis assay parameters in simultaneously evaluated thrombin generation, fibrin generation and clot lysis in normal plasma. Thromb Res 140:132–139

Article  CAS  PubMed  Google Scholar 

Shibeko AM et al (2012) Unifying the mechanism of Recombinant fviia action: dose dependence is regulated differently by tissue factor and phospholipids. Blood 120(4):891–899

Article  CAS  PubMed  PubMed Central  Google Scholar 

Woodle SA et al (2013) Determining the impact of instrument variation and automated software algorithms on the TGT in hemophilia and normalized plasma. Thromb Res 132(3):374–380

Article  CAS  PubMed  Google Scholar 

Tarandovskiy ID, Ovanesov MV (2024) The effect of factor XIa on thrombin and plasmin generation, clot formation, lysis and density in coagulation factors deficiencies. Thromb Res 233:189–199

Article  CAS  PubMed  Google Scholar 

Kumar S et al (2023) Structural analyses of beta(2)-glycoprotein I: is there a circular conformation? J Thromb Haemost 21(12):3511–3521

Article  CAS  PubMed  PubMed Central  Google Scholar 

Oviedo AE et al (2015) Absence of in vitro procoagulant activity in Immunoglobulin preparations due to activated coagulation factors. Transfus Med Hemother 42(6):397–402

Article  PubMed  PubMed Central  Google Scholar 

Shi T et al (2004) <Emphasis Type="Italic">Beta 2-glycoprotein i binds factor XI and inhibits its activation by thrombin and factor XIIa: loss of inhibition by clipped beta 2-glycoprotein i.</Emphasis>. Proc Natl Acad Sci U S A 101(11):3939–3944

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shi T et al (2005) Domain V of beta2-glycoprotein I binds factor XI/XIa and is cleaved at Lys317-Thr318. J Biol Chem 280(2):907–912

Article  CAS  PubMed  Google Scholar